Philipp Halbfaß1,2, Karin Nentwich1, Kai Sonne1, Elena Ene1, Franziska Fochler1, Andreas Mügge3, Bernhard Schieffer2, Thomas Deneke4,5. 1. Klinik für Interventionelle Rhythmologie, Herz- und Gefäßklinik GmbH Bad Neustadt, Salzburger Leite 1, 97616, Bad Neustadt a. d. Saale, Deutschland. 2. Uniklinik Marburg, Marburg, Deutschland. 3. Bergmannsheil Bochum, Ruhr-Universität Bochum, Bochum, Deutschland. 4. Klinik für Interventionelle Rhythmologie, Herz- und Gefäßklinik GmbH Bad Neustadt, Salzburger Leite 1, 97616, Bad Neustadt a. d. Saale, Deutschland. Thomas.Deneke@kardiologie-bad-neustadt.de. 5. Bergmannsheil Bochum, Ruhr-Universität Bochum, Bochum, Deutschland. Thomas.Deneke@kardiologie-bad-neustadt.de.
Abstract
BACKGROUND: The prevalence of structural heart disease increases with higher age, and thereby the basis for ventricular arrhythmias is created. Catheter ablation has been shown to be an effective therapy option that is very safe and achieves good long-term results in patients with recurrent ventricular tachycardia (VT). Data regarding ablation in patients older than 75 years is sparse, although this patient group was included as a minority in most published VT ablation studies. Data from younger patient collectives may not be transferable to older patient cohorts due to differences in patient comorbidities and baseline characteristics. METHODS: Studies with patient collectives ≥75 years or even ≥80 years show comparable efficacy of catheter ablation for VT; however, the complication rate is higher, mainly due to groin complications, increases. Catheter ablation of ischemic VT appears effective and safe even in ≥75 year olds; however, extensive data for other structural heart diseases are lacking. Epicardial procedures are also possible and safe in older patients (≥80 years). Due to the significant challenges of VT ablation in older patients, including the consideration of complex comorbidities, these should be performed in specialized centers with high expertise. CONCLUSION: The aim of catheter ablation in older patients is, above all, to improve quality of life and morbidity. Long-term survival is significantly lower due to the "near end of life" situation than in younger patients. Careful consideration of alternative therapy options, chances for success of the catheter ablation, and their risks, taking into account specific patient conditions and symptoms, is crucial in these patients.
BACKGROUND: The prevalence of structural heart disease increases with higher age, and thereby the basis for ventricular arrhythmias is created. Catheter ablation has been shown to be an effective therapy option that is very safe and achieves good long-term results in patients with recurrent ventricular tachycardia (VT). Data regarding ablation in patients older than 75 years is sparse, although this patient group was included as a minority in most published VT ablation studies. Data from younger patient collectives may not be transferable to older patient cohorts due to differences in patient comorbidities and baseline characteristics. METHODS: Studies with patient collectives ≥75 years or even ≥80 years show comparable efficacy of catheter ablation for VT; however, the complication rate is higher, mainly due to groin complications, increases. Catheter ablation of ischemic VT appears effective and safe even in ≥75 year olds; however, extensive data for other structural heart diseases are lacking. Epicardial procedures are also possible and safe in older patients (≥80 years). Due to the significant challenges of VT ablation in older patients, including the consideration of complex comorbidities, these should be performed in specialized centers with high expertise. CONCLUSION: The aim of catheter ablation in older patients is, above all, to improve quality of life and morbidity. Long-term survival is significantly lower due to the "near end of life" situation than in younger patients. Careful consideration of alternative therapy options, chances for success of the catheter ablation, and their risks, taking into account specific patient conditions and symptoms, is crucial in these patients.
Entities:
Keywords:
Catheter ablation; Efficacy; Quality of life; Safety; Ventricular tachycardia
Authors: Eleanor B Schron; Derek V Exner; Qing Yao; Louise S Jenkins; Jonathan S Steinberg; James R Cook; Steven P Kutalek; Peter L Friedman; Rosemary S Bubien; Richard L Page; Judy Powell Journal: Circulation Date: 2002-02-05 Impact factor: 29.690
Authors: E S Zado; D J Callans; C D Gottlieb; S P Kutalek; S L Wilbur; F L Samuels; S E Hessen; C M Movsowitz; J M Fontaine; S E Kimmel; F E Marchlinski Journal: J Am Coll Cardiol Date: 2000-02 Impact factor: 24.094
Authors: Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin Journal: Circulation Date: 2004-12-06 Impact factor: 29.690
Authors: Ana Viana-Tejedor; José L Merino; Armando Pérez-Silva; Rocío Cózar León; Sara Moreno Reviriego; Eva Díaz Caraballo; Rafael Peinado Peinado; José L López-Sendón Journal: Rev Esp Cardiol Date: 2010-02 Impact factor: 4.753
Authors: Vivek Y Reddy; Matthew R Reynolds; Petr Neuzil; Allison W Richardson; Milos Taborsky; Krit Jongnarangsin; Stepan Kralovec; Lucie Sediva; Jeremy N Ruskin; Mark E Josephson Journal: N Engl J Med Date: 2007-12-27 Impact factor: 91.245
Authors: Andrew E Epstein; G Neal Kay; Vance J Plumb; H Thomas McElderry; Harish Doppalapudi; Takumi Yamada; Jeff Shafiroff; Zaffer A Syed; Sergio Shkurovich Journal: Heart Rhythm Date: 2009-04-10 Impact factor: 6.343
Authors: Keiichi Inada; Kurt C Roberts-Thomson; Jens Seiler; Daniel Steven; Usha B Tedrow; Bruce A Koplan; William G Stevenson Journal: Heart Rhythm Date: 2010-02-16 Impact factor: 6.343